Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Sukeyuki, Nakamura"'
Autor:
Tetsuo Fujita, Nami Hayama, Tsuguko Kuroki, Yuka Shiraishi, Hiroyuki Amano, Makoto Nakamura, Satoshi Hirano, Nao Aramaki, Shuji Ichinose, Shinichiro Shimizu, Hiroshi Tabeta, Sukeyuki Nakamura
Publikováno v:
Thoracic Cancer, Vol 10, Iss 11, Pp 2179-2182 (2019)
The safety of treatment with immune‐checkpoint inhibitors prior to thoracic surgery in patients with non‐small cell lung cancer (NSCLC) remains unclear. Here, we describe the case of a 62‐year‐old woman with NSCLC with programmed death ligand
Externí odkaz:
https://doaj.org/article/f9e3b252545f479a9f0a72c5574f0bcb
Autor:
Tetsuo Fujita, Hiroyuki Amano, Makoto Nakamura, Rintaro Ishikawa, Toshiaki Inazaki, Yuki Urano, Satoshi Hirano, Sukeyuki Nakamura
Publikováno v:
Respiratory Investigation. 61:508-510
Autor:
Asako Yanagisawa, Satoshi Hirano, Shinichiro Shimizu, Takuma Hiroishi, Kohei Shikano, Noriko Hayama, Tetsuo Fujita, Hiroyuki Amano, Makoto Nakamura, Sukeyuki Nakamura, Hiroshi Tabeta
Publikováno v:
Case Reports in Oncological Medicine, Vol 2017 (2017)
We present a case of metastatic recurrence of carcinoid tumor accompanied by carcinoid syndrome in a 68-year-old Japanese man, 12 years after resection of typical pulmonary carcinoid. Histopathologic examination from percutaneous liver biopsy reveale
Externí odkaz:
https://doaj.org/article/402f9963546b4a8da0c315858f1677d4
Autor:
Chiaki Iwamura, Kiyoshi Hirahara, Masahiro Kiuchi, Sanae Ikehara, Kazuhiko Azuma, Tadanaga Shimada, Sachiko Kuriyama, Syota Ohki, Emiri Yamamoto, Yosuke Inaba, Yuki Shiko, Ami Aoki, Kota Kokubo, Rui Hirasawa, Takahisa Hishiya, Kaori Tsuji, Tetsutaro Nagaoka, Satoru Ishikawa, Akira Kojima, Haruki Mito, Ryota Hase, Yasunori Kasahara, Naohide Kuriyama, Tetsuya Tsukamoto, Sukeyuki Nakamura, Takashi Urushibara, Satoru Kaneda, Seiichiro Sakao, Minoru Tobiume, Yoshio Suzuki, Mitsuhiro Tsujiwaki, Terufumi Kubo, Tadashi Hasegawa, Hiroshi Nakase, Osamu Nishida, Kazuhisa Takahashi, Komei Baba, Yoko Iizumi, Toshiya Okazaki, Motoko Y. Kimura, Ichiro Yoshino, Hidetoshi Igari, Hiroshi Nakajima, Takuji Suzuki, Hideki Hanaoka, Taka-aki Nakada, Yuzuru Ikehara, Koutaro Yokote, Toshinori Nakayama
Publikováno v:
Proceedings of the National Academy of Sciences. 119
The mortality of coronavirus disease 2019 (COVID-19) is strongly correlated with pulmonary vascular pathology accompanied by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection–triggered immune dysregulation and aberrant activati
Autor:
Kodai Kawamura, Hidekazu Matsushima, Hiroshi Sakai, Akira Iwashima, Sukeyuki Nakamura, Tohru Kojima, Shinichi Sasaki, Takehiko Shigenaga, Ichiro Natsume, Takaaki Sasaki, Yoshinobu Ohsaki, Kentaro Iwanaga, Koichi Nishi, Yoichiro Mitsuishi, Hirokazu Taniguchi, Kazuhiro Sato, Mitsugu Yamauchi, Motowo Nakajima, Kazuhisa Takahashi
Publikováno v:
Oncology. 100(11)
Introduction: Cisplatin-based chemotherapy was established in the 1980s, and it has been improved by the development of a short hydration protocol in lung cancer therapy. However, cisplatin-based chemotherapy is still associated with renal toxicity.
Autor:
Hiroshi Tabeta, Nami Hayama, Satoshi Hirano, Tsuguko Kuroki, Sukeyuki Nakamura, Hiroyuki Amano, Makoto Nakamura, Takashi Aruga, Yuka Shiraishi, Tetsuo Fujita
Publikováno v:
Haigan. 60:187-191
Autor:
Tsuguko Kuroki, Hiroyuki Amano, Satoshi Hirano, Yuka Shiraishi, Sukeyuki Nakamura, Hiroshi Tabeta, Nami Hayama, Makoto Nakamura, Tetsuo Fujita, Shinichiro Shimizu
Publikováno v:
Journal of Thoracic Oncology. 15:e20-e22
Autor:
Nao Aramaki, Shuji Ichinose, Nami Hayama, Shinichiro Shimizu, Satoshi Hirano, Makoto Nakamura, Tetsuo Fujita, Hiroshi Tabeta, Hiroyuki Amano, Tsuguko Kuroki, Sukeyuki Nakamura, Yuka Shiraishi
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 10, Iss 11, Pp 2179-2182 (2019)
Thoracic Cancer, Vol 10, Iss 11, Pp 2179-2182 (2019)
The safety of treatment with immune‐checkpoint inhibitors prior to thoracic surgery in patients with non‐small cell lung cancer (NSCLC) remains unclear. Here, we describe the case of a 62‐year‐old woman with NSCLC with programmed death ligand
Autor:
Satoshi Hirano, Hidekazu Takahashi, Amano Hiroyuki, Inazaki Toshiaki, Tsuguko Kuroki, Akira Urano, Fujihiro Kure, Tetsuo Fujita, Makoto Nakamura, Sukeyuki Nakamura
Publikováno v:
Annals of Oncology. 33:S535
Autor:
Nami Hayama, Satoshi Hirano, Sukeyuki Nakamura, Hiroshi Tabeta, Tsuguko Kuroki, Yuka Shiraishi, Makoto Nakamura, Tetsuo Fujita, Hiroyuki Amano
Publikováno v:
Internal Medicine
Objective Pembrolizumab has benefited patients with advanced non-small-cell lung cancer (NSCLC) with a programmed death-ligand (PD-L) 1 high expression, but little information is available regarding its safety for patients with interstitial lung dis